Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis.

@article{Wells2008ResponsivenessOP,
  title={Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis.},
  author={George A Wells and Tracy T Li and Lara Maxwell and Ross J Maclean and Peter Tugwell},
  journal={Annals of the rheumatic diseases},
  year={2008},
  volume={67 2},
  pages={260-5}
}
OBJECTIVE To evaluate the responsiveness of patient reported outcomes (PROs), including fatigue, sleep, activity limitation, and quality of life, in patients with rheumatoid arthritis (RA). METHODS Data were considered from a randomised controlled trial comparing abatacept (n = 258) with placebo (n = 133) on a background of DMARD treatment in RA patients who were inadequate responders to anti-TNF therapy (ATTAIN study). PROs assessed included SF-36, activity limitation, fatigue, and sleep… CONTINUE READING